Medacta gains clearance for cervical interbody fusion device

The FDA provided Medacta clearance for its Mecta-C Stand Alone anterior cervical fusion device.

Advertisement

Three insights:

1. Mecta-C is designed for use in C2 to T1 in skeletally mature patients suffering from degenerative disc disease.

2. The device’s modular design enables surgeons to intraoperatively select four plating options to fit patients’ needs.

3. Mecta-C is offered in TiPEEK, a plasma-sprayed titanium coating that improves stability and migration resistance.

More articles on devices:
Rothman Orthopaedics surgeon to lead orthopedic oncology program
New Southeastern Spine Institute moves closer to completion
Kevin Lobo’s 8+ years as Stryker CEO: Leading 20+ acquisitions, boosting robotics & more

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.